Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRMINE: Inflammatory Response in Major Injury & Recombinant Human Erythropoietin – Pilot Study
2015-002255-10Phase 2Completed
- Sponsor
- Swansea Bay University Health Board
- Start
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of epoetin alfa in multiple organ dysfunction syndrome (MODS) and immunocompromise, sponsored by Swansea Bay University Health Board. Primary endpoint: Feasibility of recruitment and trial procedures. Started Jun 2016; status: completed.
02
Drugs
epoetin alfa
03
Conditions
multiple organ dysfunction syndrome (MODS)immunocompromise
Beyond the preview
Go deeper on 2015-002255-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002255-10.